Publication Name	World Journal of Hepatology
Manuscript ID	28132
Country	United States

Received	2016-06-27 11:59
Peer-Review Started	2016-06-27 14:21
To Make the First Decision	2016-08-26 08:16
Return for Revision	2016-08-29 17:03
Revised	2016-09-23 21:01
Second Decision	2016-11-22 17:40
Accepted by Journal Editor-in-Chief	2016-11-22 23:51
Accepted by Executive Editor-in-Chief	2016-12-02 10:34
Articles in Press	2016-12-02 10:34
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-01-04 15:46
Publish the Manuscript Online	2017-01-16 10:39

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Prospective Study
Article Title	Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort
Manuscript Source	Invited Manuscript
All Author List	Lukasz A Myc, Jonathan G Stine, Rinita Chakrapani, Alexandra Kadl and Curtis K Argo
Funding Agency and Grant Number
Corresponding Author	Curtis K Argo, MD, MS, Division of Gastroenterology and Hepatology, University of Virginia, JPA and Lee Street, MSB 2145, PO Box 800708, Charlottesville, VA 22908, United States. cka3d@virginia.edu
Key Words	Portal hypertension; Vasopressor; Liver; Intensive care unit; Hepatology
Core Tip	Although the management of septic shock has evolved dramatically in recent decades, data regarding optimal vasopressor therapy in critically-ill patients with cirrhosis is less robust and is based largely on con-sensus expert opinion. We found no difference in 7-d or 28-d mortality with vasopressin use when compared to all other vasoactive agents as a second line agent in catecholamine-resistant septic shock. Further large-scale studies are needed to refine current con-sensus standards and provide further support to our findings.
Publish Date	2017-01-16 10:39
Citation	Myc LA, Stine JG, Chakrapani R, Kadl A, Argo CK. Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort. World J Hepatol 2017; 9(2): 106-113
URL	http://www.wjgnet.com/1948-5182/full/v9/i2/106.htm
DOI	http://dx.doi.org/10.4254/wjh.v9.i2.106

Full Article (PDF)	WJH-9-106.pdf
Full Article (Word)	WJH-9-106.doc
Manuscript File	28132-Review.docx
Answering Reviewers	28132-Answering reviewers.pdf
Audio Core Tip	28132-Audio core tip.m4a
Biostatistics Review Certificate	28132-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	28132-Conflict-of-interest statement.pdf
Copyright License Agreement	28132-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	28132-Institutional review board statement.pdf
Peer-review Report	28132-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	28132-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	28132-Scientific misconduct check.pdf
Scientific Editor Work List	28132-Scientific editor work list.pdf